Wall Cardiovascular Technologies LLC agreed to settlements with two of the four major drug-eluting stent makers it’s accused of patent infringement, leaving Abbott (NYSE:ABT) and Johnson & Johnson (NYSE:JNJ) subsidiary Cordis Corp. as the remaining defendants.